Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Anesthesia Patient Safety Foundation
'Ozempic breath' sparks questions as users report strange side effect Those taking GLP-1 (glucagon-like peptide-1) medications for diabetes and weight loss often experience gastrointestinal symptoms but some lesser-known side effects have also been reported
Clin Gastroenterol Hepatol (2022) 20:13821393.e19
Clinical Implications: What This Means for Patients As I consider the landmark Afrin study findings alongside the broader anti-inflammatory research, I'm struck by the potential implications for patients with: Mast cell activation syndrome and related histamine-mediated conditions (read about my 9 Powerful Treatments for MCAS) now with compelling evidence showing 89% clinical improvement rates Autoimmune diseases involving chronic inflammation (learn about the connection between infections and autoimmune conditions) Neuroinflammatory conditions including chronic pain syndromes Cardiovascular disease with inflammatory components Chronic fatigue potentially linked to inflammatory processes (explore how hidden infections may be causing your fatigue and the fascinating similarities between Long COVID and chronic fatigue) Thyroid dysfunction , particularly Hashimoto's thyroiditis and other inflammatory thyroid conditions The Afrin study researchers emphasize that randomized controlled trials are needed to fully assess efficacy and identify optimal dosing protocols for GLP-1 receptor agonist treatment in MCAS and other inflammatory conditions
US$ 27.61
US$ 26.99
US$ 20.00
US$ 29.66
US$ 25.57
US$ 21.01
US$ 29.08
US$ 20.05
